
    
      Patients will fast 24 hours before and 24 hours after the administration of chemotherapy
      which will consist of doxorubicin plus cyclophosphamide every 2 weeks for four cycles
      followed by paclitaxel every 2 weeks for four cycles (dose-dense AC + T) or docetaxel (T)
      every 3 weeks for four cycles. Trastuzumab (H) and Pertuzumab (P) will be given concurrently
      with docetaxel for a total of 4 cycles before surgery. For patients who do not achieve
      pathological complete remission (pCR), adjuvant chemotherapy with doxorubicin (A) plus
      cyclophosphamide (C) every 3 weeks for four cycles will be given, followed by trastuzumab
      every 3 weeks to complete 1 year of treatment. For patients with pCR, only trastuzumab every
      3 weeks will be given adjuvantly to complete 1 year of treatment (TPH + AC).
    
  